ATM and cancer: As healthy cells do not have the same restricted DNA repair capacity typically found in cancer cells [43], we suggested that healthy cells—fibroblasts in our model system—should adapt better to inhibition of DDR, while targeting ATR or ATM with specific inhibitors.